ethylmaleimide has been researched along with Lupus Erythematosus, Systemic in 2 studies
Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taylor, RP | 1 |
| Burge, J | 1 |
| Horgan, C | 1 |
| Shasby, DM | 1 |
| Dolgova-Korubin, V | 1 |
| Simova, N | 1 |
2 other studies available for ethylmaleimide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Topics: Antigen-Antibody Complex; Complement C2; Complement C3; Complement C4; DNA; Erythrocytes; Ethylmalei | 1983 |
Unusual bone marrow visualization with 99mTc-damaged erythrocytes.
Topics: Bone Marrow; Child; Erythrocytes; Ethylmaleimide; Female; Humans; Lupus Erythematosus, Systemic; Rad | 1982 |